Piper Jaffray started coverage on shares of ICU Medical, Incorporated (NASDAQ: ICUI)
Separately, analysts at Zacks downgraded shares of ICU Medical, Incorporated from an ?outperform? rating to a ?neutral? rating in a research note to investors on Monday, December 24th. They now have a $64.90 price target on the stock.
Five investment analysts have rated the stock with a buy rating, and one has given an overweight rating to the company. The stock presently has a consensus rating of ?buy? and an average price target of $69.50.
Shares of ICU Medical, Incorporated traded up 0.03% during mid-day trading on Friday, hitting $59.77. ICU Medical, Incorporated has a 52 week low of $45.40 and a 52 week high of $64.25. The stock?s 50-day moving average is currently $59.65. The company has a market cap of $864.7 million and a P/E ratio of 21.34. ICU Medical, Incorporated last released its earnings data on Monday, February 4th. The company reported $0.82 earnings per share for the quarter, beating the analysts? consensus estimate of $0.78 by $0.04. The company had revenue of $82.70 million for the quarter, compared to the consensus estimate of $82.69 million. During the same quarter in the prior year, the company posted $0.70 earnings per share. The company?s quarterly revenue was up 8.1% on a year-over-year basis. ICU Medical, Incorporated has set its FY13 guidance at $2.70-2.85 EPS. On average, analysts predict that ICU Medical, Incorporated will post $2.78 earnings per share for the current fiscal year.
ICU Medical, Inc. is engaged in the development, manufacture and sale of disposable medical connection systems for use in vascular therapy applications.